CME Information
Overview
Provider Statement
This continuing education activity is provided by 
Educational Partner: 
Support Statement
This activity is supported by educational grants from AbbVie Inc. and Takeda Pharmaceuticals U.S.A., Inc.
There is no non-commercial support for this activity.
Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.
Target Audience
The intended audience for this activity is gastroenterology physician assistants, nurse practitioners, nurses, pharmacists, and other health care professionals involved in the management of patients with inflammatory bowel disease.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Apply the latest medical advances, including biological therapies, to the treatment of patients with IBD.
- Summarize surgical procedures used for IBD and approaches to reduce complications.
- Evaluate everyday challenges as well as practical interventions and solutions that may improve the overall outcome and quality of life in patients with IBD.
- Assess the significance of a multidisciplinary approach in the optimal management of patients with IBD in both the medical and surgical settings.
Course Co-Chairs
Russell D. Cohen, MD, FACG, AGAF
Professor of Medicine, Pritzker School of Medicine
Director, Inflammatory Bowel Disease Center
University of Chicago Medicine
Chicago, IL
David T. Rubin, MD
Joseph B. Kirsner Professor of Medicine
Section Chief, Gastroenterology, Hepatology and Nutrition
Inflammatory Bowel Disease Center
University of Chicago Medicine
Chicago, IL
Faculty
Mary Ayers, BSN-RN
Nurse Manager
Inflammatory Bowel Disease Center
University of Chicago Medicine
Chicago, IL
Janice C. Colwell, APRN, CWOCN, FAAN
Advanced Practice Nurse, Ostomy and Wound Care
Inflammatory Bowel Disease Center
University of Chicago Medicine
Chicago, IL
Emily A. Dobrez, BSN, MSN, FNP
Nurse Practitioner
Inflammatory Bowel Disease Center
University of Chicago Medicine
Chicago, IL
Sarah O’Rourke, DNP, APRN, AGPCNP-BC
Nurse Practitioner
University of Chicago Medicine Digestive Diseases Center
Chicago, IL
Michele Rubin, MSN, APN, CNS, CGRN
IBD Clinical Nurse Specialist
Director, Advanced Practice Nursing
Associate Director
Inflammatory Bowel Disease Center
University of Chicago Medicine
Chicago, IL
Planners/Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Jennifer Frederick, PharmD, BCPS
Linda A. Giarraputo, PA-C
Jennifer Labas, APN, FNP-BC
Barbara A. Niedz, PhD, RN, CPHQ
Accreditation
Vindico Medical Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
Credit Designation
Vindico Medical Education will provide a maximum of 1.75 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
This program is acceptable for 1.75 contact hour of Accreditation Council for Pharmacy Education (ACPE) Continuing Education Credit. The ACPE Universal Program Number is 0482-9999-22-001-H01-P, effective 1/31/2022. This is a knowledge-based activity and there is no fee to attend.
Vindico Medical Education will provide pharmacist credits claimed information directly to the ACPE through CPE Monitor within 30 days.
This activity is approved for 1.75 contact hour(s) of continuing education (which includes 0.75 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 22015313. This activity was planned in accordance with AANP Accreditation Standards and Policies.
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 1/31/2022 to 1/30/2023. AAPA reference number: CME-204411.
This enduring material is approved for 1 year from the date of original release, January 31, 2022, to January 30, 2023.
How to Participate in This Activity and Obtain CE Credit
To participate in this CE activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AAPA Category 1 Credit Certificate, CPE Statement of Credit, or Contact Hours Certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity
Course Co-Chairs and Faculty report the following relevant relationship(s)
Mary Ayers, BSN-RN
No relevant financial relationships to disclose.
Russell D. Cohen, MD, FACG, AGAF
Consultant: AbbVie, Bristol-Myer Squibb/Celgene, Genentech, Gilead, Hoffman LaRoche, Janssen, Lilly, Pfizer, Takeda, UCB
Speaker Contracted by Ineligible Company: AbbVie, Takeda
Independent Research Contractor: AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb/Celgene, Genentech, Gilead, Hollister, MedImmune, Mesoblast, Osiris, Pfizer, Receptos, RedHill Biopharma, Sanofi-Aventis, Schwarz Pharma, Seres, Takeda, UCB
Janice C. Colwell, APRN, CWOCN, FAAN
Consultant: Coloplast
Emily A. Dobrez, BSN, MSN, FNP
Advisor: Bristol-Myers Squibb
Sarah O’Rourke, DNP, APRN, AGPCNP-BC
No relevant financial relationships to disclose.
David T. Rubin, MD
Consultant: AbbVie, AltruBio, Allergan, Arena, Athos, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene/Syneos, Connect Biopharma, Genentech/Roche, Gilead, InDex Pharmaceuticals, Ironwood Pharmaceuticals, Iterative Scopes, Janssen, Lilly, Pfizer, Prometheus, Reistone, Takeda, Techlab
Independent Research Contractor: Takeda
Michele Rubin, MSN, APN, CNS, CGRN
No relevant financial relationships to disclose.
Planners and Reviewers report the following relevant relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Jennifer Frederick, PharmD, BCPS
Linda A. Giarraputo, PA-C
Jennifer Labas, APN, FNP-BC
Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2022 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com